Pharmacokinetics of Nevirapine in HIV Infected Children from Resource Limited Settings Using Fixed Dose Anti-retroviral Combinations

Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 12, Issue 3

Abstract

Introduction: The pharmacokinetics of nevirapine in paediatric populations are important to consider for those receiving anti-retroviral treatment in resource limited settings. High rate of adherence is required to achieve therapeutic success with good record keeping system for monitoring and follow-ups. Discussion: Children up to 2 years old have a higher rate of elimination for nevirapine compared to adult population and older children. Elimination rate in children less than 8 years are about twice those in adults. Prescriptions for the drug based on body surface area have been found to be too complex for use in resource limited settings and calculations based on weight bands are used. Though weight bands make drug administration easier the lower weight bands are likely to receive sub therapeutic doses when drug is administered especially when adult fixed dose combinations are used. Chewable paediatric tablets offer better pharmacokinetic profile compared to liquids or oral tablets, however availability of such dosage forms remains low. Solid dosage forms tend to give better nevirapine exposure when taken whole and not broken into halves or quarters as is the case in resource limited settings. Absorption and bioavailability of nevirapine may be affected by nutritional status when they is changes in fat/lean body mass ratio and physiological function due to malnutrition. Conclusion: Effective antiretroviral treatment is limited by low availability of formulations for nevirapine only or fixed dose combinations for use in paediatric populations. Paediatric formulations are more accurate in achieving trough concentrations and sufficient nevirapine exposure. Adult tablets usually have to be broken in halves or quarters and this can affect the bioavailability of nevirapine and lead to sub therapeutic concentrations.

Authors and Affiliations

Tapiwa E. Manyarara, S. Khoza, C. C. Maponga

Keywords

Related Articles

Serum CA19–9 Levels and Pancreatic Beta Cell Destruction in Type 2 Diabetes Mellitus Patients

Carbohydrate antigen 19–9 (CA 19–9) is a tumor–associated antigen, which is used in the diagnosis of pancreatic cancer but is also a marker of pancreatic tissue damage that might be caused by diabetes. The aim of this st...

Development of a Monolithic HPLC-ECD Method for the Determination of Ropinirole HCl in Mouse Sera and Dosage Forms

Aim: A highly selective, sensitive, and rapid to establish an innovative way to determine Ropinirole HCl in mouse sera and pharmaceutical formulations. Study Design: High-performance liquid chromatography (HPLC) method...

In silico Identification of Novel Potential BACE-1 Inhibitors for Alzheimer’s Disease Treatment: Molecular Docking, Pharmacophore Modeling and Activity and Synthetic Accessibility Predictions

Aims: Alzheimer's Disease (AD) is a progressive neurodegenerative disease accompanied by loss of memory and cognition. With its causes still unknown, one of the main hypotheses related to its pathogenesis is the amyloida...

Effects of Aqueous Extract of Some Selected Vegetables on Halofantrine Hepato-cardiatoxicity in Rats

Aim: The protective effect of some selected vegetables {Moringa (Moringa oleifera), Cabbage (Brassica oleracea) and Tomato (Solanum lycopersicum)} against hepato- cardio toxicity of halofantrine (an antimalarial drug) wa...

Isolation and Characterization of β-Sitosterol-3-O-β-D-glucoside from the Extract of the Flowers of Viola odorata

Isolation from the ethanol extract of the flowers of Viola odorata resulted in the isolation of β-Sitosterol-β-D-glucoside. This compound has not been previously isolated or reported from the flowers of this variety. The...

Download PDF file
  • EP ID EP342183
  • DOI 10.9734/BJPR/2016/27392
  • Views 79
  • Downloads 0

How To Cite

Tapiwa E. Manyarara, S. Khoza, C. C. Maponga (2016). Pharmacokinetics of Nevirapine in HIV Infected Children from Resource Limited Settings Using Fixed Dose Anti-retroviral Combinations. Journal of Pharmaceutical Research International, 12(3), 1-8. https://europub.co.uk/articles/-A-342183